Aridis Pharmaceuticals Inc. Banner Image

Aridis Pharmaceuticals Inc. has reached its limit for free report views

Work for Aridis Pharmaceuticals Inc.? Upgrade Your Profile and unlock all your annual reports.

Aridis Pharmaceuticals Inc.

  • Ticker ARDS
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Aridis Pharmaceuticals Inc. Logo Image
  • 11-50 Employees
  • Based in San Jose, California
Aridis Pharmaceuticals, Inc. discovers and develops anti-infectives to be used as add-on treatments to standard-of-care antibiotics. The Company is utilizing its proprietary ʎPEX™ and MabIgX® technology platforms to rapidly identify rare, potent antibody-producing B-cells from patients who have successfully overcome an infection, and to rapidly manufacture monoclonal antibody (mAbsMore) for therapeutic treatment of critical infections. These mAbs are already of human origin and functionally optimized for high potency by the donor's immune system; hence, they do not require genetic engineering or further optimization to achieve full functionality.
Aridis Pharmaceuticals Inc.

Most Recent Annual Report

Aridis Pharmaceuticals Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Aridis Pharmaceuticals Inc. has reached its limit for free report views.

Older/Archived Annual Reports